| Date | Time | Source | Announcement |
|---|---|---|---|
| 14 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 09 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 08 Dec 2005 | 07:01 AM | Licensing Agreement | |
| 08 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 07 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 02 Dec 2005 | 04:00 PM | Director/PDMR Shareholding | |
| 02 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 01 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 30 Nov 2005 | 04:00 PM | Holding(s) in Company | |
| 29 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 24 Nov 2005 | 04:00 PM | Holding(s) in Company | |
| 24 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 23 Nov 2005 | 04:00 PM | Holding(s) in Company | |
| 22 Nov 2005 | 07:01 AM | Nexium | |
| 22 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 21 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 18 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 17 Nov 2005 | 04:00 PM | Holding(s) in Company | |
| 17 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 16 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 15 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 14 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 11 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 10 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 09 Nov 2005 | 07:00 AM | Seroquel | |
| 07 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 04 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 03 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 01 Nov 2005 | 04:30 PM | Holding(s) in Company | |
| 31 Oct 2005 | 01:30 PM | Zactima | |
| 31 Oct 2005 | 07:00 AM | Transaction in Own Shares | |
| 28 Oct 2005 | 04:00 PM | Holding(s) in Company | |
| 27 Oct 2005 | 11:00 AM | 3rd Quarter Results (2 of 2) | |
| 27 Oct 2005 | 11:00 AM | 3rd Quarter Results (1 of 2) | |
| 26 Oct 2005 | 09:00 AM | Notice of Results | |
| 21 Oct 2005 | 07:00 AM | Seroquel | |
| 18 Oct 2005 | 07:00 AM | Nexium ANDA | |
| 03 Oct 2005 | 07:00 AM | Transaction in Own Shares | |
| 29 Sep 2005 | 07:00 AM | Transaction in Own Shares | |
| 28 Sep 2005 | 10:53 AM | Seroquel ANDA | |
| 28 Sep 2005 | 07:00 AM | Transaction in Own Shares | |
| 23 Sep 2005 | 03:30 PM | Regulatory Application | |
| 22 Sep 2005 | 07:00 AM | Transaction in Own Shares | |
| 21 Sep 2005 | 07:00 AM | Transaction in Own Shares | |
| 20 Sep 2005 | 07:00 AM | Transaction in Own Shares | |
| 16 Sep 2005 | 07:00 AM | Transaction in Own Shares | |
| 15 Sep 2005 | 07:00 AM | Transaction in Own Shares | |
| 14 Sep 2005 | 07:00 AM | Transaction in Own Shares | |
| 13 Sep 2005 | 07:00 AM | Transaction in Own Shares | |
| 09 Sep 2005 | 07:00 AM | Transaction in Own Shares |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.